Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Excellent Long-Term Survival and Immune Recovery With Reduced-Intensity Conditioning HCT in Inborn Errors of Immunity.
Journal: Transplantation and cellular therapy
Published: February 03, 2026
Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: October 13, 2021
Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies.
Journal: Pediatric blood & cancer
Published: February 22, 2021
High-dose chemotherapy and autologous hematopoietic stem-cell rescue for treatment of relapsed and refractory Wilms tumor: Re-evaluating outcomes.
Journal: Pediatric hematology and oncology
Published: January 26, 2019
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: May 02, 2018
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.
Journal: The New England journal of medicine
Published: April 19, 2018
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.
Journal: Blood
Published: March 26, 2018
Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: September 14, 2017
Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma.
Journal: Bone marrow transplantation
Published: August 28, 2017
Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease.
Journal: Hematology/oncology and stem cell therapy
Published: June 13, 2017
Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants.
Journal: Journal of pediatric hematology/oncology
Published: May 25, 2017
Last Updated: 09/26/2026